22. Clinical benefit table: Hyalgan versus NSAID. Dichotomous outcome measures.
Study | Time | Treatment group | Outcome | No. improved | No. of pts | Risk (%) | Risk Difference | NNT |
Altman 1998 | 14‐26 wk | T: Hyalgan | Number of patients with moderate/marked pain | 69 | 105 | 66 | 4% | 25 |
C: Naproxen | 70 | 113 | 62 |